Bryn Mawr Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-29,000	Closed	-$267K	–	73
2017 Q1	$267K	Hold	29,000	–	–	0.27%	60
2016 Q4	$302K	Buy	+29,000	New	+$302K	0.31%	56